• All sections
  • C - Chemistrymetallurgy
  • C07C - Acyclic or carbocyclic compounds
  • C07C 275/30 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups

Patent holdings for IPC class C07C 275/30

Total number of patents in this class: 175

10-year publication summary

11
16
20
10
12
11
9
6
7
8
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Allergan, Inc.
2319
21
Molecular Insight Pharmaceuticals, Inc.
56
7
Texas Tech University System
601
6
The General Hospital Corporation
4794
5
The Broad Institute, Inc.
1862
5
Bristol-myers Squibb Company
4847
4
The Regents of the University of California
20211
4
Glaxosmithkline Intellectual Property Development Limited
770
4
Massachusetts Institute of Technology
10131
4
Arena Pharmaceuticals, Inc.
362
4
RTI International
20
4
Arete Therapeutics, Inc.
23
3
Suzhou Zelgen Biopharmaceutical Co., Ltd.
13
3
University of Pittsburgh - Of the Commonwealth System of Higher Education
3204
3
Firmenich Incorporated
151
3
Abbott Laboratories
2383
2
The Johns Hopkins University
5737
2
Duke University
3101
2
Arpida AG
2
2
Korea University Research and Business Foundation
3061
2
Other owners 85